464 related articles for article (PubMed ID: 22020326)
21. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways.
Pan R; Dai Y; Gao XH; Lu D; Xia YF
Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410
[TBL] [Abstract][Full Text] [Related]
22. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
[TBL] [Abstract][Full Text] [Related]
23. A biphasic endothelial stress-survival mechanism regulates the cellular response to vascular endothelial growth factor A.
Latham AM; Odell AF; Mughal NA; Issitt T; Ulyatt C; Walker JH; Homer-Vanniasinkam S; Ponnambalam S
Exp Cell Res; 2012 Nov; 318(18):2297-311. PubMed ID: 22796052
[TBL] [Abstract][Full Text] [Related]
24. Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer.
Rydén L; Linderholm B; Nielsen NH; Emdin S; Jönsson PE; Landberg G
Breast Cancer Res Treat; 2003 Dec; 82(3):147-54. PubMed ID: 14703061
[TBL] [Abstract][Full Text] [Related]
25. Targeting tumor-associated endothelial cells: anti-VEGFR2 immunoliposomes mediate tumor vessel disruption and inhibit tumor growth.
Wicki A; Rochlitz C; Orleth A; Ritschard R; Albrecht I; Herrmann R; Christofori G; Mamot C
Clin Cancer Res; 2012 Jan; 18(2):454-64. PubMed ID: 22065082
[TBL] [Abstract][Full Text] [Related]
26. ARNO regulates VEGF-dependent tissue responses by stabilizing endothelial VEGFR-2 surface expression.
Mannell HK; Pircher J; Chaudhry DI; Alig SK; Koch EG; Mettler R; Pohl U; Krötz F
Cardiovasc Res; 2012 Jan; 93(1):111-9. PubMed ID: 22002459
[TBL] [Abstract][Full Text] [Related]
27. VEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathway.
Kumar B; Chile SA; Ray KB; Reddy GE; Addepalli MK; Kumar AS; Ramana V; Rajagopal V
Angiogenesis; 2011 Sep; 14(3):371-80. PubMed ID: 21698469
[TBL] [Abstract][Full Text] [Related]
28. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
29. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
[TBL] [Abstract][Full Text] [Related]
30. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
31. Multimerin-2 maintains vascular stability and permeability.
Pellicani R; Poletto E; Andreuzzi E; Paulitti A; Doliana R; Bizzotto D; Braghetta P; Colladel R; Tarticchio G; Sabatelli P; Bucciotti F; Bressan G; Iozzo RV; Colombatti A; Bonaldo P; Mongiat M
Matrix Biol; 2020 May; 87():11-25. PubMed ID: 31422156
[TBL] [Abstract][Full Text] [Related]
32. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
[TBL] [Abstract][Full Text] [Related]
33. A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.
Rastelli L; Valentino ML; Minderman MC; Landin J; Malyankar UM; Lescoe MK; Kitson R; Brunson K; Souan L; Forenza S; Goldfarb RH; Rabbani SA
Int J Oncol; 2011 Aug; 39(2):401-8. PubMed ID: 21567086
[TBL] [Abstract][Full Text] [Related]
34. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
Ngan BY; Forte V; Campisi P
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
[TBL] [Abstract][Full Text] [Related]
35. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
[TBL] [Abstract][Full Text] [Related]
36. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.
Tang N; Wang L; Esko J; Giordano FJ; Huang Y; Gerber HP; Ferrara N; Johnson RS
Cancer Cell; 2004 Nov; 6(5):485-95. PubMed ID: 15542432
[TBL] [Abstract][Full Text] [Related]
37. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization.
Li B; Sharpe EE; Maupin AB; Teleron AA; Pyle AL; Carmeliet P; Young PP
FASEB J; 2006 Jul; 20(9):1495-7. PubMed ID: 16754748
[TBL] [Abstract][Full Text] [Related]
38. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
[TBL] [Abstract][Full Text] [Related]
39. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
40. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
